Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Data on the number of cases for these diseases from the pre-vaccine era is hard to come by, and even the case counts are extremely unreliable. Many estimates suggest that perhaps only 10 percent of ...

Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...

The contract, signed in the final days of the Biden administration, is designed to help Moderna develop and test the safety and efficacy of vaccines to protect against five subtypes of influenza ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.

Moderna (MRNA) stock in focus as the company aims a 2027 marketing nod for Merck (MRK) partnered skin cancer vaccine. Read ...

The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

Highly pathogenic avian influenza continues to devastate poultry flocks throughout the United States, as well as cause ...